nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—ALB—Vismodegib—skin cancer	0.227	0.322	CbGbCtD
Cefazolin—ABCC4—Fluorouracil—skin cancer	0.218	0.309	CbGbCtD
Cefazolin—ALB—Vemurafenib—skin cancer	0.179	0.255	CbGbCtD
Cefazolin—ALB—Fluorouracil—skin cancer	0.0806	0.114	CbGbCtD
Cefazolin—PON1—blood vessel—skin cancer	0.0127	0.392	CbGeAlD
Cefazolin—PON1—lymphoid tissue—skin cancer	0.00477	0.147	CbGeAlD
Cefazolin—PON1—head—skin cancer	0.00384	0.118	CbGeAlD
Cefazolin—Abdominal pain upper—Vismodegib—skin cancer	0.00337	0.0128	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00333	0.0127	CcSEcCtD
Cefazolin—Nephropathy toxic—Bleomycin—skin cancer	0.00332	0.0126	CcSEcCtD
Cefazolin—Drug fever—Docetaxel—skin cancer	0.0032	0.0122	CcSEcCtD
Cefazolin—TPMT—nipple—skin cancer	0.0028	0.0861	CbGeAlD
Cefazolin—Vaginal inflammation—Imiquimod—skin cancer	0.00268	0.0102	CcSEcCtD
Cefazolin—Local reaction—Fluorouracil—skin cancer	0.00267	0.0102	CcSEcCtD
Cefazolin—Vaginal infection—Imiquimod—skin cancer	0.00253	0.00963	CcSEcCtD
Cefazolin—Oral candidiasis—Temozolomide—skin cancer	0.00253	0.00963	CcSEcCtD
Cefazolin—Hepatic function abnormal—Imiquimod—skin cancer	0.00223	0.00848	CcSEcCtD
Cefazolin—Heartburn—Fluorouracil—skin cancer	0.00215	0.00819	CcSEcCtD
Cefazolin—Cholestasis—Temozolomide—skin cancer	0.00212	0.00805	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00206	0.00782	CcSEcCtD
Cefazolin—Eosinophilia—Vemurafenib—skin cancer	0.00195	0.00743	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00174	0.00664	CcSEcCtD
Cefazolin—Oral candidiasis—Docetaxel—skin cancer	0.00168	0.0064	CcSEcCtD
Cefazolin—Aplastic anaemia—Dactinomycin—skin cancer	0.00167	0.00635	CcSEcCtD
Cefazolin—TPMT—mammalian vulva—skin cancer	0.00163	0.0503	CbGeAlD
Cefazolin—Vaginal inflammation—Temozolomide—skin cancer	0.00161	0.00612	CcSEcCtD
Cefazolin—Mouth ulceration—Dactinomycin—skin cancer	0.00161	0.00611	CcSEcCtD
Cefazolin—Phlebitis—Bleomycin—skin cancer	0.00161	0.00611	CcSEcCtD
Cefazolin—Dyspepsia—Vismodegib—skin cancer	0.0016	0.00608	CcSEcCtD
Cefazolin—Pancytopenia—Imiquimod—skin cancer	0.0016	0.00608	CcSEcCtD
Cefazolin—Decreased appetite—Vismodegib—skin cancer	0.00158	0.00601	CcSEcCtD
Cefazolin—Liver disorder—Docetaxel—skin cancer	0.00157	0.00597	CcSEcCtD
Cefazolin—Fatigue—Vismodegib—skin cancer	0.00157	0.00596	CcSEcCtD
Cefazolin—Heartburn—Docetaxel—skin cancer	0.00155	0.00591	CcSEcCtD
Cefazolin—Pain—Vismodegib—skin cancer	0.00155	0.00591	CcSEcCtD
Cefazolin—Candida infection—Temozolomide—skin cancer	0.00153	0.00584	CcSEcCtD
Cefazolin—Vaginal infection—Temozolomide—skin cancer	0.00152	0.00577	CcSEcCtD
Cefazolin—Aplastic anaemia—Temozolomide—skin cancer	0.00151	0.00574	CcSEcCtD
Cefazolin—Phlebitis—Dactinomycin—skin cancer	0.0015	0.0057	CcSEcCtD
Cefazolin—Erythema multiforme—Vemurafenib—skin cancer	0.00149	0.00568	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00149	0.00566	CcSEcCtD
Cefazolin—Gastrointestinal pain—Vismodegib—skin cancer	0.00148	0.00565	CcSEcCtD
Cefazolin—SLC22A11—female reproductive system—skin cancer	0.00148	0.0455	CbGeAlD
Cefazolin—Abdominal pain—Vismodegib—skin cancer	0.00144	0.00546	CcSEcCtD
Cefazolin—Haemoglobin—Imiquimod—skin cancer	0.00135	0.00515	CcSEcCtD
Cefazolin—Haemorrhage—Imiquimod—skin cancer	0.00135	0.00512	CcSEcCtD
Cefazolin—Asthenia—Vismodegib—skin cancer	0.0013	0.00496	CcSEcCtD
Cefazolin—Pruritus—Vismodegib—skin cancer	0.00128	0.00489	CcSEcCtD
Cefazolin—Erythema multiforme—Imiquimod—skin cancer	0.00127	0.00485	CcSEcCtD
Cefazolin—Diarrhoea—Vismodegib—skin cancer	0.00124	0.00473	CcSEcCtD
Cefazolin—TPMT—head—skin cancer	0.00117	0.036	CbGeAlD
Cefazolin—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00116	0.00442	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00116	0.00442	CcSEcCtD
Cefazolin—Vomiting—Vismodegib—skin cancer	0.00115	0.00439	CcSEcCtD
Cefazolin—Rash—Vismodegib—skin cancer	0.00114	0.00436	CcSEcCtD
Cefazolin—Dermatitis—Vismodegib—skin cancer	0.00114	0.00435	CcSEcCtD
Cefazolin—Pancytopenia—Bleomycin—skin cancer	0.00114	0.00432	CcSEcCtD
Cefazolin—Blood bilirubin increased—Docetaxel—skin cancer	0.00113	0.0043	CcSEcCtD
Cefazolin—Anaphylactic shock—Vemurafenib—skin cancer	0.00112	0.00427	CcSEcCtD
Cefazolin—Nausea—Vismodegib—skin cancer	0.00108	0.0041	CcSEcCtD
Cefazolin—Agitation—Imiquimod—skin cancer	0.00108	0.0041	CcSEcCtD
Cefazolin—Pancytopenia—Dactinomycin—skin cancer	0.00106	0.00403	CcSEcCtD
Cefazolin—Syncope—Imiquimod—skin cancer	0.00105	0.004	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00105	0.004	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00105	0.004	CcSEcCtD
Cefazolin—Hypotension—Vemurafenib—skin cancer	0.00105	0.00399	CcSEcCtD
Cefazolin—Neutropenia—Dactinomycin—skin cancer	0.00104	0.00397	CcSEcCtD
Cefazolin—Stomatitis—Bleomycin—skin cancer	0.00104	0.00395	CcSEcCtD
Cefazolin—Loss of consciousness—Imiquimod—skin cancer	0.00103	0.00392	CcSEcCtD
Cefazolin—Colitis—Docetaxel—skin cancer	0.00103	0.0039	CcSEcCtD
Cefazolin—Candida infection—Docetaxel—skin cancer	0.00102	0.00388	CcSEcCtD
Cefazolin—Convulsion—Imiquimod—skin cancer	0.00102	0.00387	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000985	0.00375	CcSEcCtD
Cefazolin—Decreased appetite—Vemurafenib—skin cancer	0.000975	0.00371	CcSEcCtD
Cefazolin—Stomatitis—Dactinomycin—skin cancer	0.000969	0.00369	CcSEcCtD
Cefazolin—Fatigue—Vemurafenib—skin cancer	0.000967	0.00368	CcSEcCtD
Cefazolin—Haemoglobin—Bleomycin—skin cancer	0.000962	0.00366	CcSEcCtD
Cefazolin—Pancytopenia—Temozolomide—skin cancer	0.000958	0.00364	CcSEcCtD
Cefazolin—Haemorrhage—Bleomycin—skin cancer	0.000957	0.00364	CcSEcCtD
Cefazolin—Lightheadedness—Docetaxel—skin cancer	0.000956	0.00364	CcSEcCtD
Cefazolin—Neutropenia—Temozolomide—skin cancer	0.000943	0.00359	CcSEcCtD
Cefazolin—Shock—Imiquimod—skin cancer	0.000941	0.00358	CcSEcCtD
Cefazolin—Agranulocytosis—Dactinomycin—skin cancer	0.000928	0.00353	CcSEcCtD
Cefazolin—Eosinophilia—Fluorouracil—skin cancer	0.00092	0.0035	CcSEcCtD
Cefazolin—Anorexia—Imiquimod—skin cancer	0.000912	0.00347	CcSEcCtD
Cefazolin—Phlebitis—Docetaxel—skin cancer	0.0009	0.00343	CcSEcCtD
Cefazolin—Hepatitis—Dactinomycin—skin cancer	0.000892	0.0034	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000891	0.00339	CcSEcCtD
Cefazolin—Body temperature increased—Vemurafenib—skin cancer	0.000887	0.00337	CcSEcCtD
Cefazolin—Pancytopenia—Fluorouracil—skin cancer	0.000882	0.00336	CcSEcCtD
Cefazolin—Stomatitis—Temozolomide—skin cancer	0.000876	0.00333	CcSEcCtD
Cefazolin—Somnolence—Imiquimod—skin cancer	0.000851	0.00324	CcSEcCtD
Cefazolin—Erythema multiforme—Dactinomycin—skin cancer	0.000844	0.00321	CcSEcCtD
Cefazolin—Dyspepsia—Imiquimod—skin cancer	0.000842	0.0032	CcSEcCtD
Cefazolin—ABCC4—female reproductive system—skin cancer	0.000841	0.0259	CbGeAlD
Cefazolin—Decreased appetite—Imiquimod—skin cancer	0.000832	0.00316	CcSEcCtD
Cefazolin—Hypersensitivity—Vemurafenib—skin cancer	0.000827	0.00315	CcSEcCtD
Cefazolin—Fatigue—Imiquimod—skin cancer	0.000825	0.00314	CcSEcCtD
Cefazolin—TPMT—lymph node—skin cancer	0.000818	0.0252	CbGeAlD
Cefazolin—Pain—Imiquimod—skin cancer	0.000818	0.00311	CcSEcCtD
Cefazolin—Haemoglobin—Temozolomide—skin cancer	0.000811	0.00309	CcSEcCtD
Cefazolin—Stomatitis—Fluorouracil—skin cancer	0.000807	0.00307	CcSEcCtD
Cefazolin—Haemorrhage—Temozolomide—skin cancer	0.000807	0.00307	CcSEcCtD
Cefazolin—Hepatitis—Temozolomide—skin cancer	0.000807	0.00307	CcSEcCtD
Cefazolin—Asthenia—Vemurafenib—skin cancer	0.000805	0.00306	CcSEcCtD
Cefazolin—Pruritus—Vemurafenib—skin cancer	0.000794	0.00302	CcSEcCtD
Cefazolin—Feeling abnormal—Imiquimod—skin cancer	0.000788	0.003	CcSEcCtD
Cefazolin—Gastrointestinal pain—Imiquimod—skin cancer	0.000782	0.00298	CcSEcCtD
Cefazolin—Agranulocytosis—Fluorouracil—skin cancer	0.000773	0.00294	CcSEcCtD
Cefazolin—Anaemia—Bleomycin—skin cancer	0.00077	0.00293	CcSEcCtD
Cefazolin—Diarrhoea—Vemurafenib—skin cancer	0.000768	0.00292	CcSEcCtD
Cefazolin—Erythema multiforme—Temozolomide—skin cancer	0.000763	0.0029	CcSEcCtD
Cefazolin—Urticaria—Imiquimod—skin cancer	0.00076	0.00289	CcSEcCtD
Cefazolin—Abdominal pain—Imiquimod—skin cancer	0.000756	0.00288	CcSEcCtD
Cefazolin—Body temperature increased—Imiquimod—skin cancer	0.000756	0.00288	CcSEcCtD
Cefazolin—Haemoglobin—Fluorouracil—skin cancer	0.000747	0.00284	CcSEcCtD
Cefazolin—Leukopenia—Bleomycin—skin cancer	0.000745	0.00284	CcSEcCtD
Cefazolin—Haemorrhage—Fluorouracil—skin cancer	0.000744	0.00283	CcSEcCtD
Cefazolin—Dizziness—Vemurafenib—skin cancer	0.000742	0.00282	CcSEcCtD
Cefazolin—Anaemia—Dactinomycin—skin cancer	0.000718	0.00273	CcSEcCtD
Cefazolin—Vomiting—Vemurafenib—skin cancer	0.000713	0.00271	CcSEcCtD
Cefazolin—Abdominal pain upper—Docetaxel—skin cancer	0.000709	0.0027	CcSEcCtD
Cefazolin—Rash—Vemurafenib—skin cancer	0.000707	0.00269	CcSEcCtD
Cefazolin—Dermatitis—Vemurafenib—skin cancer	0.000707	0.00269	CcSEcCtD
Cefazolin—Hypersensitivity—Imiquimod—skin cancer	0.000705	0.00268	CcSEcCtD
Cefazolin—Headache—Vemurafenib—skin cancer	0.000703	0.00267	CcSEcCtD
Cefazolin—ABCC4—head—skin cancer	0.000702	0.0216	CbGeAlD
Cefazolin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000699	0.00266	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000699	0.00266	CcSEcCtD
Cefazolin—SLC22A8—head—skin cancer	0.000697	0.0215	CbGeAlD
Cefazolin—Leukopenia—Dactinomycin—skin cancer	0.000695	0.00265	CcSEcCtD
Cefazolin—Asthenia—Imiquimod—skin cancer	0.000686	0.00261	CcSEcCtD
Cefazolin—Confusional state—Bleomycin—skin cancer	0.000685	0.00261	CcSEcCtD
Cefazolin—Anaphylactic shock—Bleomycin—skin cancer	0.00068	0.00259	CcSEcCtD
Cefazolin—Pruritus—Imiquimod—skin cancer	0.000677	0.00258	CcSEcCtD
Cefazolin—Nausea—Vemurafenib—skin cancer	0.000666	0.00254	CcSEcCtD
Cefazolin—Thrombocytopenia—Bleomycin—skin cancer	0.000666	0.00253	CcSEcCtD
Cefazolin—Diarrhoea—Imiquimod—skin cancer	0.000655	0.00249	CcSEcCtD
Cefazolin—Anaemia—Temozolomide—skin cancer	0.000649	0.00247	CcSEcCtD
Cefazolin—Anorexia—Bleomycin—skin cancer	0.000648	0.00247	CcSEcCtD
Cefazolin—Agitation—Temozolomide—skin cancer	0.000646	0.00246	CcSEcCtD
Cefazolin—Pancytopenia—Docetaxel—skin cancer	0.000637	0.00242	CcSEcCtD
Cefazolin—Hypotension—Bleomycin—skin cancer	0.000635	0.00242	CcSEcCtD
Cefazolin—Dizziness—Imiquimod—skin cancer	0.000633	0.00241	CcSEcCtD
Cefazolin—Leukopenia—Temozolomide—skin cancer	0.000629	0.00239	CcSEcCtD
Cefazolin—Neutropenia—Docetaxel—skin cancer	0.000627	0.00239	CcSEcCtD
Cefazolin—Thrombocytopenia—Dactinomycin—skin cancer	0.000621	0.00236	CcSEcCtD
Cefazolin—Convulsion—Temozolomide—skin cancer	0.000609	0.00232	CcSEcCtD
Cefazolin—Vomiting—Imiquimod—skin cancer	0.000608	0.00231	CcSEcCtD
Cefazolin—Anorexia—Dactinomycin—skin cancer	0.000604	0.0023	CcSEcCtD
Cefazolin—Rash—Imiquimod—skin cancer	0.000603	0.0023	CcSEcCtD
Cefazolin—Dermatitis—Imiquimod—skin cancer	0.000603	0.00229	CcSEcCtD
Cefazolin—Headache—Imiquimod—skin cancer	0.000599	0.00228	CcSEcCtD
Cefazolin—Anaemia—Fluorouracil—skin cancer	0.000598	0.00228	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000593	0.00226	CcSEcCtD
Cefazolin—Decreased appetite—Bleomycin—skin cancer	0.000591	0.00225	CcSEcCtD
Cefazolin—Renal failure—Docetaxel—skin cancer	0.000588	0.00224	CcSEcCtD
Cefazolin—Stomatitis—Docetaxel—skin cancer	0.000583	0.00222	CcSEcCtD
Cefazolin—Pain—Bleomycin—skin cancer	0.000581	0.00221	CcSEcCtD
Cefazolin—Leukopenia—Fluorouracil—skin cancer	0.000579	0.0022	CcSEcCtD
Cefazolin—Confusional state—Temozolomide—skin cancer	0.000578	0.0022	CcSEcCtD
Cefazolin—Anaphylactic shock—Temozolomide—skin cancer	0.000573	0.00218	CcSEcCtD
Cefazolin—Nausea—Imiquimod—skin cancer	0.000568	0.00216	CcSEcCtD
Cefazolin—Thrombocytopenia—Temozolomide—skin cancer	0.000561	0.00214	CcSEcCtD
Cefazolin—Convulsion—Fluorouracil—skin cancer	0.000561	0.00213	CcSEcCtD
Cefazolin—Feeling abnormal—Bleomycin—skin cancer	0.00056	0.00213	CcSEcCtD
Cefazolin—Agranulocytosis—Docetaxel—skin cancer	0.000558	0.00212	CcSEcCtD
Cefazolin—Decreased appetite—Dactinomycin—skin cancer	0.000551	0.0021	CcSEcCtD
Cefazolin—Fatigue—Dactinomycin—skin cancer	0.000547	0.00208	CcSEcCtD
Cefazolin—Anorexia—Temozolomide—skin cancer	0.000547	0.00208	CcSEcCtD
Cefazolin—Pain—Dactinomycin—skin cancer	0.000542	0.00206	CcSEcCtD
Cefazolin—Urticaria—Bleomycin—skin cancer	0.00054	0.00205	CcSEcCtD
Cefazolin—Haemoglobin—Docetaxel—skin cancer	0.000539	0.00205	CcSEcCtD
Cefazolin—Body temperature increased—Bleomycin—skin cancer	0.000537	0.00204	CcSEcCtD
Cefazolin—Haemorrhage—Docetaxel—skin cancer	0.000537	0.00204	CcSEcCtD
Cefazolin—Hepatitis—Docetaxel—skin cancer	0.000537	0.00204	CcSEcCtD
Cefazolin—Confusional state—Fluorouracil—skin cancer	0.000533	0.00203	CcSEcCtD
Cefazolin—Anaphylactic shock—Fluorouracil—skin cancer	0.000528	0.00201	CcSEcCtD
Cefazolin—Feeling abnormal—Dactinomycin—skin cancer	0.000522	0.00199	CcSEcCtD
Cefazolin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000518	0.00197	CcSEcCtD
Cefazolin—Thrombocytopenia—Fluorouracil—skin cancer	0.000517	0.00197	CcSEcCtD
Cefazolin—Somnolence—Temozolomide—skin cancer	0.00051	0.00194	CcSEcCtD
Cefazolin—ALB—lymph node—skin cancer	0.000508	0.0156	CbGeAlD
Cefazolin—Erythema multiforme—Docetaxel—skin cancer	0.000507	0.00193	CcSEcCtD
Cefazolin—Dyspepsia—Temozolomide—skin cancer	0.000505	0.00192	CcSEcCtD
Cefazolin—Anorexia—Fluorouracil—skin cancer	0.000504	0.00192	CcSEcCtD
Cefazolin—Abdominal pain—Dactinomycin—skin cancer	0.000501	0.00191	CcSEcCtD
Cefazolin—Body temperature increased—Dactinomycin—skin cancer	0.000501	0.00191	CcSEcCtD
Cefazolin—Hypersensitivity—Bleomycin—skin cancer	0.000501	0.00191	CcSEcCtD
Cefazolin—Decreased appetite—Temozolomide—skin cancer	0.000498	0.0019	CcSEcCtD
Cefazolin—Fatigue—Temozolomide—skin cancer	0.000494	0.00188	CcSEcCtD
Cefazolin—Hypotension—Fluorouracil—skin cancer	0.000494	0.00188	CcSEcCtD
Cefazolin—ABCC4—lymph node—skin cancer	0.000492	0.0151	CbGeAlD
Cefazolin—Pain—Temozolomide—skin cancer	0.00049	0.00187	CcSEcCtD
Cefazolin—Asthenia—Bleomycin—skin cancer	0.000488	0.00186	CcSEcCtD
Cefazolin—Pruritus—Bleomycin—skin cancer	0.000481	0.00183	CcSEcCtD
Cefazolin—Feeling abnormal—Temozolomide—skin cancer	0.000472	0.0018	CcSEcCtD
Cefazolin—Somnolence—Fluorouracil—skin cancer	0.00047	0.00179	CcSEcCtD
Cefazolin—Gastrointestinal pain—Temozolomide—skin cancer	0.000469	0.00178	CcSEcCtD
Cefazolin—Hypersensitivity—Dactinomycin—skin cancer	0.000467	0.00178	CcSEcCtD
Cefazolin—Dyspepsia—Fluorouracil—skin cancer	0.000465	0.00177	CcSEcCtD
Cefazolin—Decreased appetite—Fluorouracil—skin cancer	0.000459	0.00175	CcSEcCtD
Cefazolin—Urticaria—Temozolomide—skin cancer	0.000455	0.00173	CcSEcCtD
Cefazolin—Asthenia—Dactinomycin—skin cancer	0.000455	0.00173	CcSEcCtD
Cefazolin—Body temperature increased—Temozolomide—skin cancer	0.000453	0.00172	CcSEcCtD
Cefazolin—Abdominal pain—Temozolomide—skin cancer	0.000453	0.00172	CcSEcCtD
Cefazolin—Pain—Fluorouracil—skin cancer	0.000452	0.00172	CcSEcCtD
Cefazolin—Feeling abnormal—Fluorouracil—skin cancer	0.000435	0.00166	CcSEcCtD
Cefazolin—Diarrhoea—Dactinomycin—skin cancer	0.000434	0.00165	CcSEcCtD
Cefazolin—Vomiting—Bleomycin—skin cancer	0.000432	0.00164	CcSEcCtD
Cefazolin—Anaemia—Docetaxel—skin cancer	0.000432	0.00164	CcSEcCtD
Cefazolin—Rash—Bleomycin—skin cancer	0.000429	0.00163	CcSEcCtD
Cefazolin—Dermatitis—Bleomycin—skin cancer	0.000428	0.00163	CcSEcCtD
Cefazolin—Hypersensitivity—Temozolomide—skin cancer	0.000422	0.00161	CcSEcCtD
Cefazolin—Urticaria—Fluorouracil—skin cancer	0.00042	0.0016	CcSEcCtD
Cefazolin—Syncope—Docetaxel—skin cancer	0.000419	0.00159	CcSEcCtD
Cefazolin—Leukopenia—Docetaxel—skin cancer	0.000418	0.00159	CcSEcCtD
Cefazolin—Body temperature increased—Fluorouracil—skin cancer	0.000418	0.00159	CcSEcCtD
Cefazolin—Asthenia—Temozolomide—skin cancer	0.000411	0.00157	CcSEcCtD
Cefazolin—Loss of consciousness—Docetaxel—skin cancer	0.000411	0.00156	CcSEcCtD
Cefazolin—Pruritus—Temozolomide—skin cancer	0.000406	0.00154	CcSEcCtD
Cefazolin—Convulsion—Docetaxel—skin cancer	0.000405	0.00154	CcSEcCtD
Cefazolin—Nausea—Bleomycin—skin cancer	0.000404	0.00154	CcSEcCtD
Cefazolin—Vomiting—Dactinomycin—skin cancer	0.000403	0.00153	CcSEcCtD
Cefazolin—Rash—Dactinomycin—skin cancer	0.0004	0.00152	CcSEcCtD
Cefazolin—Diarrhoea—Temozolomide—skin cancer	0.000392	0.00149	CcSEcCtD
Cefazolin—Hypersensitivity—Fluorouracil—skin cancer	0.000389	0.00148	CcSEcCtD
Cefazolin—Confusional state—Docetaxel—skin cancer	0.000384	0.00146	CcSEcCtD
Cefazolin—Anaphylactic shock—Docetaxel—skin cancer	0.000381	0.00145	CcSEcCtD
Cefazolin—Dizziness—Temozolomide—skin cancer	0.000379	0.00144	CcSEcCtD
Cefazolin—Nausea—Dactinomycin—skin cancer	0.000377	0.00143	CcSEcCtD
Cefazolin—Shock—Docetaxel—skin cancer	0.000375	0.00143	CcSEcCtD
Cefazolin—Pruritus—Fluorouracil—skin cancer	0.000374	0.00142	CcSEcCtD
Cefazolin—Thrombocytopenia—Docetaxel—skin cancer	0.000373	0.00142	CcSEcCtD
Cefazolin—Vomiting—Temozolomide—skin cancer	0.000365	0.00139	CcSEcCtD
Cefazolin—Anorexia—Docetaxel—skin cancer	0.000363	0.00138	CcSEcCtD
Cefazolin—Rash—Temozolomide—skin cancer	0.000362	0.00138	CcSEcCtD
Cefazolin—Diarrhoea—Fluorouracil—skin cancer	0.000361	0.00138	CcSEcCtD
Cefazolin—Dermatitis—Temozolomide—skin cancer	0.000361	0.00137	CcSEcCtD
Cefazolin—Headache—Temozolomide—skin cancer	0.000359	0.00137	CcSEcCtD
Cefazolin—Hypotension—Docetaxel—skin cancer	0.000356	0.00136	CcSEcCtD
Cefazolin—Dizziness—Fluorouracil—skin cancer	0.000349	0.00133	CcSEcCtD
Cefazolin—Nausea—Temozolomide—skin cancer	0.000341	0.0013	CcSEcCtD
Cefazolin—Somnolence—Docetaxel—skin cancer	0.000339	0.00129	CcSEcCtD
Cefazolin—Vomiting—Fluorouracil—skin cancer	0.000336	0.00128	CcSEcCtD
Cefazolin—Dyspepsia—Docetaxel—skin cancer	0.000336	0.00128	CcSEcCtD
Cefazolin—Rash—Fluorouracil—skin cancer	0.000333	0.00127	CcSEcCtD
Cefazolin—Dermatitis—Fluorouracil—skin cancer	0.000333	0.00127	CcSEcCtD
Cefazolin—Decreased appetite—Docetaxel—skin cancer	0.000331	0.00126	CcSEcCtD
Cefazolin—Headache—Fluorouracil—skin cancer	0.000331	0.00126	CcSEcCtD
Cefazolin—Fatigue—Docetaxel—skin cancer	0.000329	0.00125	CcSEcCtD
Cefazolin—Pain—Docetaxel—skin cancer	0.000326	0.00124	CcSEcCtD
Cefazolin—Feeling abnormal—Docetaxel—skin cancer	0.000314	0.0012	CcSEcCtD
Cefazolin—Nausea—Fluorouracil—skin cancer	0.000314	0.00119	CcSEcCtD
Cefazolin—Gastrointestinal pain—Docetaxel—skin cancer	0.000312	0.00119	CcSEcCtD
Cefazolin—Abdominal pain—Docetaxel—skin cancer	0.000301	0.00115	CcSEcCtD
Cefazolin—Body temperature increased—Docetaxel—skin cancer	0.000301	0.00115	CcSEcCtD
Cefazolin—Hypersensitivity—Docetaxel—skin cancer	0.000281	0.00107	CcSEcCtD
Cefazolin—Asthenia—Docetaxel—skin cancer	0.000274	0.00104	CcSEcCtD
Cefazolin—Pruritus—Docetaxel—skin cancer	0.00027	0.00103	CcSEcCtD
Cefazolin—Diarrhoea—Docetaxel—skin cancer	0.000261	0.000993	CcSEcCtD
Cefazolin—Dizziness—Docetaxel—skin cancer	0.000252	0.000959	CcSEcCtD
Cefazolin—Vomiting—Docetaxel—skin cancer	0.000242	0.000923	CcSEcCtD
Cefazolin—Rash—Docetaxel—skin cancer	0.00024	0.000915	CcSEcCtD
Cefazolin—Dermatitis—Docetaxel—skin cancer	0.00024	0.000914	CcSEcCtD
Cefazolin—Headache—Docetaxel—skin cancer	0.000239	0.000909	CcSEcCtD
Cefazolin—Nausea—Docetaxel—skin cancer	0.000226	0.000862	CcSEcCtD
